A group of scientists from Harvard University and other top schools have formed Syndexa Pharmaceuticals Corp., a biotechnology startup developing treatments for conditions related to obesity, according to Harvard.
A group of scientists from Harvard University and other top schools have formed Syndexa Pharmaceuticals Corp., a biotechnology startup developing treatments for conditions related to obesity, according to Harvard.
